Clinical Evidence

Our clinical evidence is built on prospective trials, head-to-head comparisons, and real-world experience across leading neurovascular centers.

0.0 %

Complete occlusion at 12 months — LIFE prospective multicenter trial

0%

In-stent stenosis rate — validated across independent comparative studies

0 %

Faster device deployment vs. conventional flow diverters

0.00

Device-to-aneurysm ratio — lowest among published FD trials

2025

Efficacy and Safety of a New Mechanical Balloon-Based Flow Diverter in the Treatment of Intracranial Aneurysms

2025

Multiple Telescoping Flow Diverter Technique in Endovascular Treatment of a Giant Petrous and Cavernous Carotid Aneurysm

2025

Retrograde Placement of Flow Diversion for the Treatment of Giant Internal Carotid Artery Aneurysm

2025

Comparison of PED Flex and Lattice Flow Diverter in the Treatment of Unruptured Intracranial Aneurysms

2025

Efficacy and Safety of a New Mechanical Balloon-Based Flow Diverter in the Treatment of Intracranial Aneurysms

2025

Multiple Telescoping Flow Diverter Technique in Endovascular Treatment of a Giant Petrous and Cavernous Carotid Aneurysm

2025

Retrograde Placement of Flow Diversion for the Treatment of Giant Internal Carotid Artery Aneurysm

2025

Comparison of PED Flex and Lattice Flow Diverter in the Treatment of Unruptured Intracranial Aneurysms

Let's Connect.

We build meaningful partnerships to drive technological innovation and improve patient outcomes worldwide. Reach out to discuss potential opportunities.